New Japan Approvals Include Tafinlar, Tagrisso

The latest batch of drug approvals in Japan includes several novel oncology products, some of which have only recently been launched elsewhere, in a sign that applicants and regulators are trying to speed up local access to important new therapies.

More from Focus On Asia

More from Scrip